Loading...
XJPX8283
Market cap1.74bUSD
Dec 27, Last price  
4,398.00JPY
1D
0.62%
1Q
-1.83%
Jan 2017
59.23%
IPO
235.38%
Name

PALTAC Corp

Chart & Performance

D1W1MN
XJPX:8283 chart
P/E
13.32
P/S
0.24
EPS
330.21
Div Yield, %
1.97%
Shrs. gr., 5y
-0.22%
Rev. gr., 5y
2.56%
Revenues
1.15t
+4.33%
737,129,000,000739,170,000,000757,557,000,000765,654,000,000785,807,000,000831,884,000,000821,095,000,000860,329,000,000922,118,000,000966,689,000,0001,015,258,000,0001,046,415,000,0001,033,265,000,0001,045,734,000,0001,104,151,000,0001,151,965,000,000
Net income
20.64b
+7.20%
8,671,000,0006,742,000,0003,430,000,0006,159,000,0008,397,000,0009,185,000,00010,268,000,00011,929,000,00014,605,000,00017,453,000,00019,767,000,00025,412,000,00019,317,000,00019,639,000,00019,251,000,00020,638,000,000
CFO
26.79b
+61.44%
11,236,000,00011,713,000,0007,359,000,0006,742,000,00011,792,000,0003,340,000,00023,204,000,0005,226,000,00024,721,000,00024,107,000,00023,565,000,00021,005,000,00028,745,000,00021,949,000,00016,594,000,00026,790,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Jan 29, 2025

Profile

Paltac Corporation engages in the wholesale of cosmetics, daily necessities, and over-the-counter drugs in Japan. The company was founded in 1898 and is headquartered in Osaka, Japan. Paltac Corporation is a subsidiary of MediPal Holdings Corporation.
URL
http://www.paltac.co.jp/
IPO date
Mar 18, 2010
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
1,151,965,000
4.33%
1,104,151,000
5.59%
1,045,734,000
1.21%
Cost of revenue
1,065,606,000
1,075,348,000
1,015,450,000
Unusual Expense (Income)
NOPBT
86,359,000
28,803,000
30,284,000
NOPBT Margin
7.50%
2.61%
2.90%
Operating Taxes
8,758,000
8,594,000
8,750,000
Tax Rate
10.14%
29.84%
28.89%
NOPAT
77,601,000
20,209,000
21,534,000
Net income
20,638,000
7.20%
19,251,000
-1.98%
19,639,000
1.67%
Dividends
(5,404,000)
(5,027,000)
(4,766,000)
Dividend yield
2.09%
1.59%
1.66%
Proceeds from repurchase of equity
(3,479,000)
BB yield
1.21%
Debt
Debt current
114,000
113,000
143,000
Long-term debt
390,000
375,000
487,000
Deferred revenue
2,949,000
2,792,000
Other long-term liabilities
3,542,000
698,000
720,000
Net debt
(89,215,000)
(69,289,000)
(61,149,000)
Cash flow
Cash from operating activities
26,790,000
16,594,000
21,949,000
CAPEX
(5,804,000)
(5,773,000)
(9,413,000)
Cash from investing activities
(6,268,000)
(6,093,000)
(10,170,000)
Cash from financing activities
(5,520,000)
(5,177,000)
(8,731,000)
FCF
73,037,000
11,225,000
14,383,000
Balance
Cash
60,994,000
45,993,000
40,670,000
Long term investments
28,725,000
23,784,000
21,109,000
Excess cash
32,120,750
14,569,450
9,492,300
Stockholders' equity
39,226,000
236,024,000
220,066,000
Invested Capital
245,028,250
244,434,550
233,557,700
ROIC
31.71%
8.46%
9.43%
ROCE
29.93%
10.87%
12.20%
EV
Common stock shares outstanding
62,846
62,846
63,284
Price
4,115.00
-18.03%
5,020.00
10.33%
4,550.00
-24.04%
Market cap
258,611,290
-18.03%
315,486,920
9.57%
287,942,200
-24.35%
EV
169,396,290
246,197,920
226,793,200
EBITDA
92,912,000
34,553,000
35,770,000
EV/EBITDA
1.82
7.13
6.34
Interest
5,000
5,000
6,000
Interest/NOPBT
0.01%
0.02%
0.02%